2007
DOI: 10.1002/art.22411
|View full text |Cite
|
Sign up to set email alerts
|

Are the classification criteria for psoriatic arthritis better than existing criteria for diagnosing psoriatic arthritis? Comment on the article by Taylor et al

Abstract: measured in a more accessible compartment, are a compatible surrogate for the hormonal environment of the knee joint.This new information also does not yet establish whether our observed associations represent the response to a receptor-mediated process (as in the case of lower estradiol concentrations) or a cytokine-based response (as in the lower urinary 2-hydroxyestrone concentrations), or potentially, both mechanisms. There is little evidence that 2-hydroxyestrogens have binding affinity to the estrogen re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
4

Year Published

2007
2007
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 8 publications
0
9
0
4
Order By: Relevance
“…Recognizing this, the CASPAR Study Group recently developed new classification criteria for PsA (2). The CASPAR criteria were derived from a study of a large cohort of patients from North America, Europe, Australasia, and Africa, which was to date the largest and most comprehensive approach by an international group to develop classification criteria for any rheumatic disease (14). The criteria are simple and highly specific (98.7%), and had a sensitivity of 91.4% in the original study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recognizing this, the CASPAR Study Group recently developed new classification criteria for PsA (2). The CASPAR criteria were derived from a study of a large cohort of patients from North America, Europe, Australasia, and Africa, which was to date the largest and most comprehensive approach by an international group to develop classification criteria for any rheumatic disease (14). The criteria are simple and highly specific (98.7%), and had a sensitivity of 91.4% in the original study.…”
Section: Discussionmentioning
confidence: 99%
“…However, the main limitation of the study was that the patients with PsA included in the study had longstanding disease (mean disease duration 12.5 years). It was therefore thought that the criteria might not perform well in patients with early disease (2, 14). To address this issue, the present study was undertaken to test the sensitivity of the criteria in early‐onset PsA.…”
Section: Discussionmentioning
confidence: 99%
“…There is still no universally accepted diagnostic criterion for PsA since it was categorized as an independent disease by the American College of Rheumatology in 1964 [5]. At present, the classification Criteria for Psoriatic Arthritis (CASPAR) [6] have been widely applied in clinical studies of PsA, owing largely to their high sensitivity and specificity [7]. However, it was originally put forward based on PsA patients with chronic conditions and requiring the presence of an inflammatory musculoskeletal precondition.…”
Section: Introductionmentioning
confidence: 99%
“…All patterns and degrees of arthritis can occur in patients with minimal skin lesions or with generalized exfoliative psoriasis. [18][19][20][21] According to the initial description by Moll and Wright in 1973, 22 the articular manifestations of PsA were classifi ed into fi ve clinical forms or distinct subgroups: monoarticular or asymmetrical oligoarticular with dactylitis, in 70% of the patients; symmetrical polyarticular similar to rheumatoid arthritis (RA), in 25% of the patients; classical form, predominantly affecting the distal interphalangeal joints, in 5%-10%; arthritis mutilans, in 5%; and spondylitic form, in 5%-40% of the patients. Further studies 23 have shown a large variation in those incidences: 16%-70% for asymmetrical oligoarthritis; 15%-78% for the polyarticular form; 1%-17% for the classical form; 2%-16% for arthritis mutilans; and 2%-27% for the spondylitic form.…”
Section: Clinical Aspectsmentioning
confidence: 99%